Key Highlights

  • TLOG is quoted at a small fraction of a cent, with a nominal market Capitalization of only a couple of thousand dollars.
  • The company filed a Form 25 delisting notice on November 14, 2016 and terminated its SEC registration weeks later.
  • Its former lead assets, birinapant and SHAPE, were reportedly transferred to another drug developer in 2016.
  • No current financial statements exist, since the company has not been an SEC reporting issuer since 2016.

The ticker TLOG still generates a sub-penny quote, which can create the impression of a company biding its time before a comeback. The reality is starkly different. TetraLogic Pharmaceuticals Corporation (OTC:TLOG) ceased to be a normal, reporting public company almost a decade ago, having Delisted from the Nasdaq and terminated its SEC registration in late 2016. What remains is a residual over-the-counter quote, not an operating Business waiting for its next catalyst.

Company and Latest Development

TetraLogic was a clinical-stage biopharmaceutical company founded in 2001 that developed small-molecule therapeutics for oncology and infectious diseases. Its best-known Assets were birinapant, a SMAC-mimetic designed to promote cancer-cell death by antagonizing inhibitor-of-apoptosis proteins, and SHAPE, a topical HDAC inhibitor explored for cutaneous T-cell lymphoma. During 2016 the company moved to monetize its pipeline and wind down its operations, a period in which its programs were widely reported to have been transferred to another drug developer. According to SEC EDGAR, TetraLogic (CIK 0001361248) filed a Form 25 delisting notice on 14 November 2016 and a Form 15-12B to terminate the registration of its securities on 2 December 2016, capping a rapid sequence of proxy and corporate filings that autumn. The filing record shows no ongoing reports after that period, consistent with a company that effectively closed its public chapter nearly a decade ago.

What Is Driving Attention Around TLOG?

No verified, current catalyst is driving the ticker. A stock that has been deregistered since 2016 does not generate the trial readouts, financings, or regulatory milestones that "next big signal" language implies. Any quote or minor price movement reflects dormant, highly Illiquid trading in a residual security rather than fresh company news. Framing TLOG as an active situation awaiting developments is not supported by the public record.

Key Numbers and Company Position

Market data show TLOG quoted around a small fraction of a cent, with a nominal market capitalization of only a couple of thousand dollars. The company was founded in 2001 and terminated SEC registration in 2016. Because it is no longer a reporting issuer, there are no current, reliable financial statements to cite, and any figures shown on data aggregators are historical or estimated rather than freshly filed. The defining fact is the absence of ongoing disclosure.

What Could Come Next?

For a deregistered shell, conventional catalysts are not on the horizon. Renewed activity would require a new operating business, a reverse-merger transaction, or a return to SEC reporting, none of which is indicated by the available record. Shell entities are occasionally used as vehicles for reverse mergers, but such outcomes are speculative and unverified here. Absent such a step, TLOG is likely to persist as an inactive, sub-penny quote with negligible informational value.

Risks to Watch

The risks are those of any deregistered penny name: no current financial reporting, extreme illiquidity, wide bid-ask spreads, and a high probability of total loss. Without audited filings, investors cannot assess assets, liabilities, or whether any value remains. Historical dilution and the lack of a Going Concern compound the uncertainty. There is no verified pipeline or Revenue base to support the shares.

Nearly a Decade Removed From Active Trading

TetraLogic Pharmaceuticals is not a company waiting for a signal but a dormant entity that delisted and deregistered in 2016 after moving to wind down its programs. For anyone encountering the TLOG ticker, the essential facts are the terminated SEC registration and the sub-penny, illiquid nature of the quote. The only meaningful development to monitor would be any filing indicating renewed operations.